Transient expression of human antibodies in mammalian cells (original) (raw)

• Begley, C.G. & Ellis, L.M. Drug development: raise standards for preclinical cancer research. Nature 483, 531–533 (2012).
  Article CAS Google Scholar
• Bradbury, A. & Pluckthun, A. Reproducibility: standardize antibodies used in research. Nature 518, 27–29 (2015).
  Article CAS Google Scholar
• Rouet, R. et al. Expression of high-affinity human antibody fragments in bacteria. Nat. Protoc. 7, 364–373 (2012).
  Article CAS Google Scholar
• Beck, A. et al. Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteins. Curr. Pharm. Biotechnol. 9, 482–501 (2008).
  Article CAS Google Scholar
• Nose, M. & Wigzell, H. Biological significance of carbohydrate chains on monoclonal antibodies. Proc. Natl. Acad. Sci. USA 80, 6632–6636 (1983).
  Article CAS Google Scholar
• Simmons, L.C. et al. Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies. J. Immunol. Methods 263, 133–147 (2002).
  Article CAS Google Scholar
• Wakelin, S.J. et al. “Dirty little secrets”—endotoxin contamination of recombinant proteins. Immunol. Lett. 106, 1–7 (2006).
  Article CAS Google Scholar
• Beutler, B. & Rietschel, E.T. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3, 169–176 (2003).
  Article CAS Google Scholar
• Schwarz, H., Schmittner, M., Duschl, A. & Horejs-Hoeck, J. Residual endotoxin contaminations in recombinant proteins are sufficient to activate human CD1c+ dendritic cells. PLoS ONE 9, e113840 (2014).
  Article Google Scholar
• Wolff, S.M. Biological effects of bacterial endotoxins in man. J. Infect. Dis. 128, S259–S264 (1973).
  Article Google Scholar
• Copeland, S. et al. Acute inflammatory response to endotoxin in mice and humans. Clin. Diagn. Lab. Immunol. 12, 60–67 (2005).
  CAS PubMed PubMed Central Google Scholar
• Frenzel, A., Hust, M. & Schirrmann, T. Expression of recombinant antibodies. Front. Immunol. 4, 217 (2013).
  Article Google Scholar
• Brooks, S.A. Protein glycosylation in diverse cell systems: implications for modification and analysis of recombinant proteins. Expert Rev. Proteomics 3, 345–359 (2006).
  Article CAS Google Scholar
• Dumont, J., Euwart, D., Mei, B., Estes, S. & Kshirsagar, R. Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives. Crit. Rev. Biotechnol. 36, 1110–1122 (2016).
  Article CAS Google Scholar
• Wurm, F.M. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotechnol. 22, 1393–1398 (2004).
  Article CAS Google Scholar
• Dalton, A.C. & Barton, W.A. Over-expression of secreted proteins from mammalian cell lines. Protein Sci. 23, 517–525 (2014).
  Article CAS Google Scholar
• Chiou, H.C. et al. Scalable transient protein expression. Methods Mol. Biol. 1104, 35–55 (2014).
  Article CAS Google Scholar
• Liu, C.Y. et al. Attaining high transient titers in CHO cells. Genetic Eng. Biotechnol. News 35, 34–35 (2015).
  Article Google Scholar
• Backliwal, G. et al. Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions. Nucleic Acids Res. 36, e96–e96 (2008).
  Article Google Scholar
• Jones, M.B. et al. Mammalian transient transfection system. Genetic Eng. Biotechnol. News 32, 50–51 (2012).
  Article Google Scholar
• Lee, C.M.Y., Iorno, N., Sierro, F. & Christ, D. Selection of human antibody fragments by phage display. Nat. Protoc. 2, 3001–3008 (2007).
  Article CAS Google Scholar
• Eisenstein, M. Living factories of the future. Nature 531, 401–403 (2016).
  Article CAS Google Scholar
• Peccoud, J. Synthetic Biology: Fostering the Cyber-Biological Revolution (Oxford University Press, 2016).
• von Boehmer, L. et al. Sequencing and cloning of antigen-specific antibodies from mouse memory B cells. Nat. Protoc. 11, 1908–1923 (2016).
  Article CAS Google Scholar
• Dodev, T.S. et al. A tool kit for rapid cloning and expression of recombinant antibodies. Sci. Rep. 4, 5885 (2014).
  Article Google Scholar
• Tiller, T., Busse, C.E. & Wardemann, H. Cloning and expression of murine Ig genes from single B cells. J. Immunol. Methods 350, 183–193 (2009).
  Article CAS Google Scholar
• Underhill, M.F., Smales, C.M., Naylor, L.H., Birch, J.R. & James, D.C. Transient gene expression levels from multigene expression vectors. Biotechnol. Prog. 23, 435–443 (2007).
  Article CAS Google Scholar
• Chng, J. et al. Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells. mAbs 7, 403–412 (2015).
  Article CAS Google Scholar
• Hacker, D.L. et al. Polyethyleneimine-based transient gene expression processes for suspension-adapted HEK-293E and CHO-DG44 cells. Protein Expr. Purif. 92, 67–76 (2013).
  Article CAS Google Scholar
• Geisse, S. Reflections on more than 10 years of TGE approaches. Protein Expr. Purif. 64, 99–107 (2009).
  Article CAS Google Scholar
• Baldi, L., Hacker, D.L., Meerschman, C. & Wurm, F.M. Large-scale transfection of mammalian cells. in Protein Expression in Mammalian Cells: Methods and Protocols 801, 13–26 (2012).
  Article CAS Google Scholar
• Lai, T., Yang, Y. & Ng, S.K. Advances in mammalian cell line development technologies for recombinant protein production. Pharmaceuticals 6, 579–603 (2013).
  Article CAS Google Scholar
• Ye, J. et al. Rapid protein production using CHO stable transfection pools. Biotechnol. Prog. 26, 1431–1437 (2010).
  Article CAS Google Scholar
• Riechmann, L., Clark, M., Waldmann, H. & Winter, G. Reshaping human antibodies for therapy. Nature 332, 323–327 (1988).
  Article CAS Google Scholar
• Jones, P.T., Dear, P.H., Foote, J., Neuberger, M.S. & Winter, G. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321, 522–525 (1986).
  Article CAS Google Scholar
• Clackson, T., Hoogenboom, H.R., Griffiths, A.D. & Winter, G. Making antibody fragments using phage display libraries. Nature 352, 624–628 (1991).
  Article CAS Google Scholar
• Jäger, V., Büssow, K. & Schirrmann, T. Transient recombinant protein expression in mammalian cells. in Animal Cell Culture 27–64 Springer, 2015).
• Vazquez-Lombardi, R. et al. Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cells. Nat. Commun. 8, 15373 (2017).
  Article CAS Google Scholar
• Kontermann, R.E. Dual targeting strategies with bispecific antibodies. Mabs 4, 182–197 (2012).
  Article Google Scholar
• GE-Healthcare. Recombinant Protein Purification: Principles and Methods (GE Healthcare Bio-Sciences AB, 2012).
• Concepcion, J. et al. Label-free detection of biomolecular interactions using BioLayer interferometry for kinetic characterization. Comb. Chem. High Throughput Screen. 12, 791–800 (2009).
  Article CAS Google Scholar
• Vasu, S. et al. High yield transient expression in mammalian cells using unique pairing of high density growth and transfection medium and expression enhancers. US Patent Application No. 13/886,226 (2013).
• Chun, B.H., Park, S.Y., Chung, N. & Bang, W.G. Enhanced production of recombinant B-domain deleted factor VIII from Chinese hamster ovary cells by propionic and butyric acids. Biotechnol. Lett. 25, 315–319 (2003).
  Article CAS Google Scholar
• Fan, S. et al. Valproic acid enhances gene expression from viral gene transfer vectors. J. Virol. Methods 125, 23–33 (2005).
  Article CAS Google Scholar
• Rodrigo, G., Gruvegård, M. & Van Alstine, J.M. Antibody fragments and their purification by protein L affinity chromatography. Antibodies 4, 259–277 (2015).
  Article CAS Google Scholar
• Petsch, D. & Anspach, F.B. Endotoxin removal from protein solutions. J. Biotechnol. 76, 97–119 (2000).
  Article CAS Google Scholar
• Malyala, P. & Singh, M. Endotoxin limits in formulations for preclinical research. J. Pharm. Sci. 97, 2041–2044 (2008).
  Article CAS Google Scholar
• Dudgeon, K. et al. General strategy for the generation of human antibody variable domains with increased aggregation resistance. Proc. Natl. Acad. Sci. USA 109, 10879–10884 (2012).
  Article CAS Google Scholar
• Haryadi, R. et al. Optimization of heavy chain and light chain signal peptides for high level expression of therapeutic antibodies in CHO cells. PLoS ONE 10, e0116878 (2015).
  Article Google Scholar
• Feige, M.J. et al. An unfolded CH1 domain controls the assembly and secretion of IgG antibodies. Mol. Cell 34, 569–579 (2009).
  Article CAS Google Scholar
• Sadhu, C., Dutta, S. & Gopinathan, K.P. Influence of formamide on the thermal stability of DNA. J. Biosci. 6, 817–821 (1984).
  Article CAS Google Scholar
• Kozak, M. Downstream secondary structure facilitates recognition of initiator codons by eukaryotic ribosomes. Proc. Natl. Acad. Sci. USA 87, 8301–8305 (1990).
  Article CAS Google Scholar
• Köhler, G. & Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495–497 (1975).
  Article Google Scholar
• Fields, C. et al. Creation of recombinant antigen-binding molecules derived from hybridomas secreting specific antibodies. Nat. Protoc. 8, 1125–1148 (2013).
  Article Google Scholar
• Overdijk, M.B. et al. Crosstalk between human IgG isotypes and murine effector cells. J. Immunol. 189, 3430–3438 (2012).
  Article CAS Google Scholar
• Musolino, A. et al. Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu–positive metastatic breast cancer. J. Clin. Oncol. 26, 1789–1796 (2008).
  Article CAS Google Scholar
• Smith, P., DiLillo, D.J., Bournazos, S., Li, F. & Ravetch, J.V. Mouse model recapitulating human Fcγ receptor structural and functional diversity. Proc. Natl. Acad. Sci. USA 109, 6181–6186 (2012).
  Article CAS Google Scholar
• Walsh, N.C. et al. Humanized mouse models of clinical disease. Annu. Rev. Pathol.: Mech. Dis. 12, 187–215 (2017).
  Article CAS Google Scholar